发明名称 |
Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
摘要 |
Use of the antimicrobial cathelicidin peptide II-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithelial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37. |
申请公布号 |
US8936807(B2) |
申请公布日期 |
2015.01.20 |
申请号 |
US201313938120 |
申请日期 |
2013.07.09 |
申请人 |
Lipopeptide AB |
发明人 |
Ståhle-Bäckdahl Mona;Heilborn Johan;Carlsson Anders;Bogentoft Conny |
分类号 |
C07K14/47;A61K9/127;A61K38/16;C12N5/00;C12N5/071 |
主分类号 |
C07K14/47 |
代理机构 |
McCarter & English, LLP |
代理人 |
McCarter & English, LLP ;Davis Steven G. |
主权项 |
1. A method for the treatment of chronic leg ulcers due to venous insufficiency, comprising administering a peptide LL-37 (SEQ ID NO: 1) or a pharmaceutically acceptable salt thereof to a subject in need of such treatment. |
地址 |
Stockholm SE |